Cellectar Biosciences, Inc. (CLRB)
CLRB
Loading signal…
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11M
- Beta
- 0.58
- P/E (TTM)
- -0.30
- Short % float
- 5.52%
- Days to cover
- 2.0
- SI change
- -13.0%
- 1W
- -7.95%
- 1M
- -39.83%
- vs SPY 1W
- -7.81%
- vs SPY 1M
- -42.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on CLRB?
- LOPJLB publishes daily direction and regime signals for CLRB on this page.
- What market regime is CLRB in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Cellectar Biosciences, Inc. (CLRB) do?
- Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Walden…